0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Companion Diagnostic Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-27J1624
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Companion Diagnostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Companion Diagnostic Market Research Report 2024

Code: QYRE-Auto-27J1624
Report
January 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Companion Diagnostic Market Size

The global Companion Diagnostic market was valued at US$ 8820 million in 2023 and is anticipated to reach US$ 32340 million by 2030, witnessing a CAGR of 20.3% during the forecast period 2024-2030.

Companion Diagnostic Market

Companion Diagnostic Market

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic.

Report Scope

The Companion Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Companion Diagnostic Market Report

Report Metric Details
Report Name Companion Diagnostic Market
Accounted market size in 2023 US$ 8820 million
Forecasted market size in 2030 US$ 32340 million
CAGR 20.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Immunohistochemistry
  • Molecular Diagnosis
Segment by Application
  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Virology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Companion Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Diagnostic Market growing?

Ans: The Companion Diagnostic Market witnessing a CAGR of 20.3% during the forecast period 2024-2030.

What is the Companion Diagnostic Market size in 2030?

Ans: The Companion Diagnostic Market size in 2030 will be US$ 32340 million.

Who are the main players in the Companion Diagnostic Market report?

Ans: The main players in the Companion Diagnostic Market are Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc

What are the Application segmentation covered in the Companion Diagnostic Market report?

Ans: The Applications covered in the Companion Diagnostic Market report are Oncology, Cardiovascular, Central Nervous System, Virology, Others

What are the Type segmentation covered in the Companion Diagnostic Market report?

Ans: The Types covered in the Companion Diagnostic Market report are Immunohistochemistry, Molecular Diagnosis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2019-2030)
2.2 Companion Diagnostic Growth Trends by Region
2.2.1 Global Companion Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Companion Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Companion Diagnostic Market Dynamics
2.3.1 Companion Diagnostic Industry Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2023
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2025-2030)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Diagnostic Market Size (2019-2030)
6.2 North America Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Diagnostic Market Size by Country (2019-2024)
6.4 North America Companion Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2019-2030)
7.2 Europe Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Diagnostic Market Size by Country (2019-2024)
7.4 Europe Companion Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2019-2030)
9.2 Latin America Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Companion Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Detail
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2019-2024)
11.1.5 Roche Holdings Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Introduction
11.5.4 Merck Revenue in Companion Diagnostic Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Agendia
11.6.1 Agendia Company Detail
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Business (2019-2024)
11.6.5 Agendia Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Introduction
11.7.4 Qiagen Revenue in Companion Diagnostic Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Detail
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Introduction
11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2019-2024)
11.8.5 Myriad Genetics Recent Development
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Detail
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2019-2024)
11.9.5 Advanced Cell Diagnostics Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Detail
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Introduction
11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2019-2024)
11.11.5 Illumina, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Immunohistochemistry
    Table 3. Key Players of Molecular Diagnosis
    Table 4. Global Companion Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Companion Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Companion Diagnostic Market Share by Region (2019-2024)
    Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Companion Diagnostic Market Share by Region (2025-2030)
    Table 10. Companion Diagnostic Market Trends
    Table 11. Companion Diagnostic Market Drivers
    Table 12. Companion Diagnostic Market Challenges
    Table 13. Companion Diagnostic Market Restraints
    Table 14. Global Companion Diagnostic Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Companion Diagnostic Market Share by Players (2019-2024)
    Table 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2023)
    Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Companion Diagnostic Product Solution and Service
    Table 21. Date of Enter into Companion Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Companion Diagnostic Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Companion Diagnostic Revenue Market Share by Type (2019-2024)
    Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Companion Diagnostic Revenue Market Share by Type (2025-2030)
    Table 27. Global Companion Diagnostic Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Companion Diagnostic Revenue Market Share by Application (2019-2024)
    Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Companion Diagnostic Revenue Market Share by Application (2025-2030)
    Table 31. North America Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Companion Diagnostic Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Companion Diagnostic Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Roche Holdings Company Detail
    Table 47. Roche Holdings Business Overview
    Table 48. Roche Holdings Companion Diagnostic Product
    Table 49. Roche Holdings Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 50. Roche Holdings Recent Development
    Table 51. Abbott Laboratories Company Detail
    Table 52. Abbott Laboratories Business Overview
    Table 53. Abbott Laboratories Companion Diagnostic Product
    Table 54. Abbott Laboratories Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 55. Abbott Laboratories Recent Development
    Table 56. Thermo Fisher Scientific Company Detail
    Table 57. Thermo Fisher Scientific Business Overview
    Table 58. Thermo Fisher Scientific Companion Diagnostic Product
    Table 59. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 60. Thermo Fisher Scientific Recent Development
    Table 61. Agilent Technologies Company Detail
    Table 62. Agilent Technologies Business Overview
    Table 63. Agilent Technologies Companion Diagnostic Product
    Table 64. Agilent Technologies Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 65. Agilent Technologies Recent Development
    Table 66. Merck Company Detail
    Table 67. Merck Business Overview
    Table 68. Merck Companion Diagnostic Product
    Table 69. Merck Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 70. Merck Recent Development
    Table 71. Agendia Company Detail
    Table 72. Agendia Business Overview
    Table 73. Agendia Companion Diagnostic Product
    Table 74. Agendia Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 75. Agendia Recent Development
    Table 76. Qiagen Company Detail
    Table 77. Qiagen Business Overview
    Table 78. Qiagen Companion Diagnostic Product
    Table 79. Qiagen Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 80. Qiagen Recent Development
    Table 81. Myriad Genetics Company Detail
    Table 82. Myriad Genetics Business Overview
    Table 83. Myriad Genetics Companion Diagnostic Product
    Table 84. Myriad Genetics Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 85. Myriad Genetics Recent Development
    Table 86. Advanced Cell Diagnostics Company Detail
    Table 87. Advanced Cell Diagnostics Business Overview
    Table 88. Advanced Cell Diagnostics Companion Diagnostic Product
    Table 89. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 90. Advanced Cell Diagnostics Recent Development
    Table 91. Danaher Company Detail
    Table 92. Danaher Business Overview
    Table 93. Danaher Companion Diagnostic Product
    Table 94. Danaher Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 95. Danaher Recent Development
    Table 96. Illumina, Inc Company Detail
    Table 97. Illumina, Inc Business Overview
    Table 98. Illumina, Inc Companion Diagnostic Product
    Table 99. Illumina, Inc Revenue in Companion Diagnostic Business (2019-2024) & (US$ Million)
    Table 100. Illumina, Inc Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Companion Diagnostic Market Share by Type: 2023 VS 2030
    Figure 3. Immunohistochemistry Features
    Figure 4. Molecular Diagnosis Features
    Figure 5. Global Companion Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Companion Diagnostic Market Share by Application: 2023 VS 2030
    Figure 7. Oncology Case Studies
    Figure 8. Cardiovascular Case Studies
    Figure 9. Central Nervous System Case Studies
    Figure 10. Virology Case Studies
    Figure 11. Others Case Studies
    Figure 12. Companion Diagnostic Report Years Considered
    Figure 13. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Companion Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Companion Diagnostic Market Share by Region: 2023 VS 2030
    Figure 16. Global Companion Diagnostic Market Share by Players in 2023
    Figure 17. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2023
    Figure 19. North America Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Companion Diagnostic Market Share by Country (2019-2030)
    Figure 21. United States Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Companion Diagnostic Market Share by Country (2019-2030)
    Figure 25. Germany Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Companion Diagnostic Market Share by Region (2019-2030)
    Figure 33. China Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Companion Diagnostic Market Share by Country (2019-2030)
    Figure 41. Mexico Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Companion Diagnostic Market Share by Country (2019-2030)
    Figure 45. Turkey Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 48. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 50. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 51. Merck Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 52. Agendia Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 53. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 54. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 55. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 56. Danaher Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 57. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS